LEITER-STÖPPKE, Ulrike, RAFEI, David Ali und UGUREL, Selma, 2020. Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter De COG study of 84 patients. Freiburg: Universität.
Elsevier - Harvard (with titles)Leiter-Stöppke, U., Rafei, D.A., Ugurel, S., 2020. Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter De COG study of 84 patients. Universität, Freiburg. https://doi.org/10.1136/jitc-2020-000897
American Psychological Association 7th editionLeiter-Stöppke, U., Rafei, D. A., & Ugurel, S. (ca. 2020). Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter De COG study of 84 patients [Cd]. Universität. https://doi.org/10.1136/jitc-2020-000897
Springer - Basic (author-date)Leiter-Stöppke U, Rafei DA, Ugurel S (2020) Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter De COG study of 84 patients. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Leiter-Stöppke, Ulrike/ Rafei, David Ali/ Ugurel, Selma, Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter De COG study of 84 patients, Freiburg 2020.